Florida has become the second U.S. state to ban fluoride in its public water systems, following a controversial trend among Republican-led states. Governor Ron DeSantis signed the legislation on Thursday, calling the addition of fluoride to tap water “forced medication.” The ban takes effect on July 1.
Fluoride, a naturally occurring mineral found in water, soil, and air, has been widely used for decades to prevent cavities and strengthen teeth. About 63% of Americans currently receive fluoridated water, according to the CDC. Public health organizations, including the American Dental Association (ADA), argue that fluoridation significantly improves dental health and poses no proven harm. However, fluoride has faced growing political opposition, especially from figures like DeSantis and Health Secretary Robert F. Kennedy Jr., who link it to health risks such as cancer and reduced cognitive function in children—claims the American Cancer Society says lack strong evidence.
DeSantis, who previously opposed public health mandates during the COVID-19 pandemic, said medical experts “shouldn’t be able to decree how we live our lives,” criticizing what he sees as overreach by health authorities.
Utah became the first state to enact a similar ban in March. Meanwhile, the FDA is currently reviewing the safety of fluoride supplements for children, signaling broader scrutiny of the mineral’s use in public health.
The ADA strongly opposes these moves, urging a thorough review before policy changes are made. President Brett Kessler emphasized the need to “slow down” and fully assess the implications of banning fluoride for national health.
The fluoride debate is intensifying as Republican states challenge long-standing public health practices, raising questions about science, personal choice, and government intervention in health policy.


AfD Wins German State Election as Merz’s CDU Hits Historic Low
Trump Scales Back Endangered Species Act Protections
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Who should own the knowledge that underpins AI technology?
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
FCC Approves Foreign Investment in $110B Paramount-Warner Bros. Deal
Australia Tightens Student Visa Rules, Targets Migration Cut by 2028
Trump Sets High-Stakes UN Meetings With Zelenskiy, Gulf Leaders
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
CNN, MS NOW and Politico Sue Trump Over White House Media Ban
Lula Meets Mamdani in New York as Elections Approach
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
FAA Allows Boeing to Sell 35 More 777F Freighters Beyond 2028
Trump Bans CNN, MS NOW and Politico From White House
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks 



